Analyst
Evercore ISI
Equibles does not estimate personal net worth.
Umur Rafat is recorded as Analyst at Evercore ISI. Umur Rafat has spoken on 5 earnings calls across 2 companies, most recently for Pfizer Inc on November 3, 2026. Those appearances were for Gilead Sciences, Inc. (GILD) and Pfizer Inc (PFE). The companies whose calls Umur Rafat spoke on are classified in the Healthcare sector.
“Albert, there's clearly been a lot of progress on SG&A improvements over the last couple of years, And I acknowledge that. It's not a step function, but there's been improvement.”
“First, on the GLIP monotherapy, could you remind us if the 9.6 milligram monthly dose was a reaction to the data today, or was that already being contemplated?”
“I noticed a $39 million sales number in 3Q. And I'm trying to make sense of it. By my rough math, it sounds like about 3,000 patients initiated in 3Q. Is that consistent with how you see it?”
“I just thought I'll spend a quick second on Simba Bay, given the recent deal.”
Evercore ISI
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
PFE
Drug Manufacturers - General · Healthcare
